Overview of the updated NCCN Clinical Practice Guidelines for systemic AL amyloidosis
Shaji Kumar, MD, Mayo Clinic, Rochester, MN, discusses updates in the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines pertaining to systemic light chain (AL) amyloidosis. Dr Kumar provides an overview of these guidelines, which emphasize matters related to diagnosis, treatment protocols for newly diagnosed and relapsing patients, and supportive care management. Dr Kumar further notes that the guidelines address potential roles for autologous stem cell transplantation (autoSCT) in amyloidosis treatment. This interview took place at the 9th World Congress on Controversies in Multiple Myeloma (COMy) 2023, held in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
-
Category
No comments found